Skip to main content
. 2020 Dec 10;56(12):681. doi: 10.3390/medicina56120681

Figure 3.

Figure 3

Tectorigenin altered the expression of CDK4 and phosphorylated RB proteins. Glioblastoma GBM-8401 cells were treated with 100, 200, and 300 μM tectorigenin for 24 h. Cell lysates were purified and subjected to western blot analysis. Quantitative data represent means ± standard deviation from three independent experiments. **: p < 0.01; ***: p < 0.001 compared with control group.